CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor	22-09-06	CI
CB Scientific, Inc. Appoints James Ott as Chief Technology Officer	22-05-03	CI
CB Scientific, Inc. Appoints Paul Danner as Chairman	21-10-28	CI
CB Scientific, Inc. Announces Appointment of Jeslie Chui as New Director for Asia Pacific	21-03-02	CI
CB Scientific, Inc. has signed a definitive agreement to acquire Cardiolink Corporation.	21-02-22	CI
CB Scientific. Inc. Announces Addition of Dozens of New Device Clinical Trials of my-Cam Device and New Hospital Monitoring Contracts Through Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd	20-12-28	CI
CB Scientific, Inc. entered into an agreement to acquire Datrix, LLC for $2.1 million.	20-11-03	CI
CB Scientific, Inc. Announces the Launch of My-Cardia ECG Products and Services in Thailand	20-10-08	CI
CB Scientific, Inc. acquired Operating Business Assets of Prevent Health Care International Corp. from Prevent Health Care International Corp.	20-09-21	CI
Apotheca Biosciences, Inc. Agrees to Exclusive License Agreement with CB Scientific	19-06-27	CI
Apotheca Biosciences and CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High	18-10-08	CI
FutureLand, Corp. acquired 20% stake in Apotheca Biosciences, Inc. from CB Scientific, Inc..	17-09-17	CI
CB Scientific, Inc. Develops three Core Platform Technologies; CannaRAPID, CannaNASAL, and CannaDERME, Focused on Precise Dosing and Controlled Release of Cannabinoid Compounds for Patients	17-06-21	CI
CB Scientific, Inc. Develops CannaRAPID, CannaNASAL and CannaDERME	17-05-15	CI
CB Scientific, Inc. Develops Cannabinoid Delivery Technologies: CannaRAPID(TM), CannaNASAL(TM) and CannaDERME(TM)	17-04-17	CI

More news

Press releases CB Scientific, Inc.

CB Scientific, Inc. 2023 Year in Review	01-12	AQ
CB Scientific : Entry into Material Definitive Agreement	22-08-23	PU
CB Scientific : For the Period Ending June 30, 2022	22-08-12	PU
CB Scientific : As of August 12, 2022	22-08-11	PU
CB Scientific : For the Annual Report for the Fiscal Year Ended March 31, 2022	22-06-28	PU

More press releases

Managers and Directors - CB Scientific, Inc.

Managers	Title	Age	Since
Charles Martin CEO	Chief Executive Officer	-	19-07-31
Brooke Martellaro DFI	Director of Finance/CFO	-	21-10-31
James Ott CTO	Chief Tech/Sci/R&D Officer	-	-

Members of the board	Title	Age	Since
Paul Danner CHM	Chairman	64	21-09-30
Charles Martin CEO	Chief Executive Officer	-	19-07-31
Robert Kelley BRD	Director/Board Member	-	-

More insiders

Company Profile

Sector

More about the company